For several cell lines including osteosarcoma cells high levels of CD44 correlate with poor prognosis and metastasis and deletion/knockout (KO) of CD44 resulted in reduced tumor cell invasion and proliferation (Liu et al., 2018; Xiao et al., 2018). The gene discussed is CD44; the disease is neoplasm.